In July, the FDA recalled the blood pressure medication valsartan because of concerns that the drug might be associated with a compound that could lead to increased cancer risks in patients. 19659003] According to CNN's report the FDA extended the recall to other blood pressure and heart failure medicines containing both valsartan and hydrochlorothiazide. A total of 22 other countries have recalled the drugs. However, the FDA has not recalled all medications that contain valsartan.
Drugs included in the recall list were manufactured in India by Hetero Labs Ltd. manufactured under the name Camber Pharmaceuticals Inc. after tests had shown that some of the products could be contaminated by N ̵
Drugs on the FDA's updated recall list include those available from AvKare, AS Medication Solutions LLC, Bryant Ranch Prepack Inc., Camber Pharmaceuticals, Inc. HJ Harkins Company, Northwind Pharmaceuticals, NuCare Pharmaceuticals Inc., Prinston Pharmaceutical Inc. (referred to as Solco Healthcare LLC), Proficient Rx LP, Remedy Repack, Teva Pharmaceuticals (referred to as Major Pharmaceuticals), Teva Pharmaceuticals USA (referred to as Actavis). "
The US Food and Drug Administration has recalled a commonly used specimen of cardiovascular medicines because some of the products may contain a carcinogenic chemical. https://t.co/US5kx81TF4
– CBS This Morning (@CBSThisMorning) Aug. 7, 2018
The recall only includes medications that are suspected of being contaminated with NDMA using a Chinese based manufacturer named Zhejiang Huahai Pharmaceuticals, located in Linhai, China. According to the company, they notified the authorities as soon as they learned that their drug might be contaminated by NDMA.
In a statement, Zhejiang Huahai Pharmaceuticals said last month, "We released our recall message on July 13 in China and overseas, and released the US market recall notice on July 14, Beijing time … all drug materials for the Chinese market were recalled until July 23. "
In addition to the recall, the FDA is also actively working with manufacturers to make sure that the active ingredients in Valsartan are not threatened by contamination.
Nearly one in three adults in the United States suffers from high blood pressure, according to a CDC report of approximately 75 million people
For patients who find their medication on the Valsartan recall list, the FDA recommends That they take the medicines as prescribed to their doctors or pharmacists I've given them a substitute form of medicine. Those who are worried should contact their doctors for the potential risk of the medication and options for switching to something else.